Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-23

FDA Approved: APOMORPHINE HYDROCLORIDE — Original Application (TruPharma, LLC)

View source ↗

Summary

FDA approved a generic apomorphine hydrochloride product under Original Application (ANDA212025) from TruPharma, LLC for use in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APOMORPHINE HYDROCHLORIDE (APOMORPHINE HYDROCHLORIDE)

Snippet

ORIG AP for APOMORPHINE HYDROCLORIDE (APOMORPHINE HYDROCHLORIDE)